glp-1 examples The promise and peril of agonists: What we do (and don't) know as of August 2024 GLP-1 Medications: Everything You Need
Description
As seen in the case presented, this rapid weight gain can result in IIH
First off, let's talk about what these GLP-1 patches are and how they're supposed to work
Wang ZJ, Han YF, Zhao F, Yang GZ, Yuan L, Cai HY, et al
Bydureon (exenatide extended-release) offered the convenience of weekly dosing and more even drug levels (blunting the peaks that cause nausea)
In a 2024 joint court filing, the two companies said that the safety profile of GLP-1 RAs has been well-established in hundreds of clinical trials, large-scale observational studies, and nearly two decades of real-world use
10.17219/acem/151695 [DOI] [PubMed] [Google Scholar] 22
